drugset / Trial / NCT02770248
24-hr Intraocular Pressure Control With SIMBRINZA ®
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate differences between treatments in mean change from baseline in 24-hr intraocular pressure (IOP) at Week 4.
Timeline
- Start
- 2016-05-23
- Primary completion
- 2017-01-14
- Completion
- 2017-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension | Unknown | — | Other |